163 related articles for article (PubMed ID: 1538028)
1. Effect of serotonin and thromboxane A2 on blood flow through moderately well developed coronary collateral vessels.
Wright L; Homans DC; Laxson DD; Dai XZ; Bache RJ
J Am Coll Cardiol; 1992 Mar; 19(3):687-93. PubMed ID: 1538028
[TBL] [Abstract][Full Text] [Related]
2. Intracoronary collagen: effects on coronary collateral circulation and the role of thromboxane.
Klassen CL; Bache RJ
J Cardiovasc Pharmacol; 2000 Jul; 36(1):90-5. PubMed ID: 10892665
[TBL] [Abstract][Full Text] [Related]
3. Effect of platelet activation on coronary collateral blood flow.
Kinn JW; Bache RJ
Circulation; 1998 Oct; 98(14):1431-7. PubMed ID: 9760298
[TBL] [Abstract][Full Text] [Related]
4. Response of canine coronary collateral vessels to ergonovine and alpha-adrenergic stimulation.
Bache RJ; Foreman B; Hautamaa PV
Am J Physiol; 1991 Oct; 261(4 Pt 2):H1019-25. PubMed ID: 1681740
[TBL] [Abstract][Full Text] [Related]
5. The thromboxane A2 mimetic U46619 worsens canine myocardial hypoperfusion during exercise in the presence of a coronary artery stenosis.
Bache RJ; Dai XZ
Cardiovasc Res; 1992 Apr; 26(4):351-6. PubMed ID: 1638566
[TBL] [Abstract][Full Text] [Related]
6. Effect of atrial natriuretic peptide on coronary collateral blood flow.
Foreman B; Dai XZ; Homans DC; Laxson DD; Bache RJ
Circ Res; 1989 Dec; 65(6):1671-8. PubMed ID: 2531047
[TBL] [Abstract][Full Text] [Related]
7. Effects of serotonin and thromboxane A2 on the coronary collateral circulation.
Buja LM; Willerson JT
J Am Coll Cardiol; 1992 Mar; 19(3):694-5. PubMed ID: 1538029
[No Abstract] [Full Text] [Related]
8. Effect of calcitonin gene-related peptide on well-developed canine coronary collateral vasculature.
Quebbeman BB; Dulas D; Altman J; Homans DC; Bache RJ
J Cardiovasc Pharmacol; 1993 May; 21(5):774-80. PubMed ID: 7685448
[TBL] [Abstract][Full Text] [Related]
9. Effect of cyclooxygenase blockade on blood flow through well-developed coronary collateral vessels.
Altman J; Dulas D; Bache RJ
Circ Res; 1992 Jun; 70(6):1091-8. PubMed ID: 1576731
[TBL] [Abstract][Full Text] [Related]
10. Endogenous adenosine and coronary vasoconstriction in hypoperfused myocardium during exercise.
Duncker DJ; Laxson DD; Lindstrom P; Bache RJ
Cardiovasc Res; 1993 Sep; 27(9):1592-7. PubMed ID: 8287435
[TBL] [Abstract][Full Text] [Related]
11. Effect of aspirin on coronary collateral blood flow.
Altman JD; Dulas D; Pavek T; Bache RJ
Circulation; 1993 Feb; 87(2):583-9. PubMed ID: 8425302
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of coronary collateral vasoconstriction in response to cyclooxygenase blockade.
Altman JD; Bache RJ
Circ Res; 1994 Feb; 74(2):310-7. PubMed ID: 8293570
[TBL] [Abstract][Full Text] [Related]
13. Role of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models with chronic coronary artery stenoses and endothelial injury.
Willerson JT; Eidt JF; McNatt J; Yao SK; Golino P; Anderson HV; Buja LM
J Am Coll Cardiol; 1991 May; 17(6 Suppl B):101B-110B. PubMed ID: 2016468
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.
Ashton JH; Schmitz JM; Campbell WB; Ogletree ML; Raheja S; Taylor AL; Fitzgerald C; Buja LM; Willerson JT
Circ Res; 1986 Nov; 59(5):568-78. PubMed ID: 3542279
[TBL] [Abstract][Full Text] [Related]
15. Endothelial function in well-developed canine coronary collateral vessels.
Altman J; Dulas D; Pavek T; Laxson DD; Homans DC; Bache RJ
Am J Physiol; 1993 Feb; 264(2 Pt 2):H567-72. PubMed ID: 8447468
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of LTC4 and TxA2 on coronary flow and myocardial function.
Nichols WW; Mehta JL; Thompson L; Donnelly WH
Am J Physiol; 1988 Jul; 255(1 Pt 2):H153-9. PubMed ID: 3394816
[TBL] [Abstract][Full Text] [Related]
17. Failure of nitroglycerin and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A2 and serotonin as mediators of coronary artery vasoconstriction in vivo.
Golino P; Buja LM; Yao SK; McNatt J; Willerson JT
J Am Coll Cardiol; 1990 Mar; 15(3):718-26. PubMed ID: 2105989
[TBL] [Abstract][Full Text] [Related]
18. Vasoconstriction of canine coronary collateral vessels with vasopressin limits blood flow to collateral-dependent myocardium during exercise.
Foreman BW; Dai XZ; Bache RJ
Circ Res; 1991 Sep; 69(3):657-64. PubMed ID: 1873862
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of coronary flow reserve and myocardial function after temporary subtotal coronary artery occlusion and increased myocardial oxygen demand in dogs.
Nichols WW; Nicolini FA; Yang B; Robbins WC; Katopodis J; Chen L; Saldeen TG; Mehta JL
J Am Coll Cardiol; 1994 Sep; 24(3):795-803. PubMed ID: 8077555
[TBL] [Abstract][Full Text] [Related]
20. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
Kamijo T; Iwai T; Haruta K; Takeda K
Arch Int Pharmacodyn Ther; 1996; 331(3):273-84. PubMed ID: 9124999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
